Literature DB >> 28317533

Genetics of Vitiligo.

Richard A Spritz1, Genevieve H L Andersen2.   

Abstract

Vitiligo reflects simultaneous contributions of multiple genetic risk factors and environmental triggers. Genomewide association studies have discovered approximately 50 genetic loci contributing to vitiligo risk. At many vitiligo susceptibility loci, the relevant genes and DNA sequence variants are identified. Many encode proteins involved in immune regulation, several play roles in cellular apoptosis, and others regulate functions of melanocytes. Although many of the specific biologic mechanisms need elucidation, it is clear that vitiligo is an autoimmune disease involving a complex relationship between immune system programming and function, aspects of the melanocyte autoimmune target, and dysregulation of the immune response.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Gene; Genetic epidemiology; Genetic linkage; Genomewide association study; Vitiligo

Mesh:

Substances:

Year:  2017        PMID: 28317533      PMCID: PMC5362127          DOI: 10.1016/j.det.2016.11.013

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  79 in total

1.  [Familial vitiligo].

Authors:  H TEINDEL
Journal:  Z Haut Geschlechtskr       Date:  1950-12-01

2.  Association of vitiligo with HLA-A2: a meta-analysis.

Authors:  J-B Liu; M Li; H Chen; S-Q Zhong; S Yang; W-D Du; J-H Hao; T-S Zhang; X-J Zhang; M P Zeegers
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-02       Impact factor: 6.166

3.  HLA antigens and vitiligo in an American black population.

Authors:  R B Kachru; M Telischi; K K Mittal
Journal:  Tissue Antigens       Date:  1978-11

4.  HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset.

Authors:  Pamela R Fain; Sunanda R Babu; Dorothy C Bennett; Richard A Spritz
Journal:  Pigment Cell Res       Date:  2006-02

5.  Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Katherine Gowan; Sheri L Riccardi; Paulene J Holland; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2011-02-17       Impact factor: 8.551

Review 6.  A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo.

Authors:  P K Das; R M van den Wijngaard; A Wankowicz-Kalinska; I C Le Poole
Journal:  Trends Immunol       Date:  2001-03       Impact factor: 16.687

7.  CTLA4 and generalized vitiligo: two genetic association studies and a meta-analysis of published data.

Authors:  Stanca A Birlea; Greggory S Laberge; Lucia M Procopciuc; Pamela R Fain; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2009-01-17       Impact factor: 4.693

8.  Common variants in FOXP1 are associated with generalized vitiligo.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Christina M Mailloux; Sheri L Riccardi; Katherine Gowan; Paulene J Holland; Dorothy C Bennett; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

9.  Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.

Authors:  Andrea Paradisi; Stefano Tabolli; Biagio Didona; Luciano Sobrino; Nicoletta Russo; Damiano Abeni
Journal:  J Am Acad Dermatol       Date:  2014-09-19       Impact factor: 11.527

10.  Three new single nucleotide polymorphisms identified by a genome-wide association study in Korean patients with vitiligo.

Authors:  Kyung Ah Cheong; Nan-Hyung Kim; Minsoo Noh; Ai-Young Lee
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

View more
  38 in total

Review 1.  The Role of Memory CD8+ T Cells in Vitiligo.

Authors:  Rebecca L Riding; John E Harris
Journal:  J Immunol       Date:  2019-07-01       Impact factor: 5.422

Review 2.  The genetic architecture of vitiligo.

Authors:  Genevieve H L Roberts; Stephanie A Santorico; Richard A Spritz
Journal:  Pigment Cell Melanoma Res       Date:  2019-12-04       Impact factor: 4.693

Review 3.  The convergence theory for vitiligo: A reappraisal.

Authors:  Roopal V Kundu; Julia M Mhlaba; Stephanie M Rangel; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2018-06-28       Impact factor: 3.960

4.  scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in Treg function.

Authors:  Kyle J Gellatly; James P Strassner; Kingsley Essien; Maggi Ahmed Refat; Rachel L Murphy; Anthony Coffin-Schmitt; Amit G Pandya; Andrea Tovar-Garza; Michael L Frisoli; Xueli Fan; Xiaolan Ding; Evangeline E Kim; Zainab Abbas; Patrick McDonel; Manuel Garber; John E Harris
Journal:  Sci Transl Med       Date:  2021-09-08       Impact factor: 17.956

5.  Association between the CTLA4 +49A/G (rs231775) and CT60 (rs3087243) gene variants with vitiligo: study on a Mexican population.

Authors:  Mauricio Andrés Salinas-Santander; Víctor de Jesús Suárez-Valencia; Mayela Del Ángel-Martínez; David Emmanuel Kubelis-Lopez; Natalia Aranza Zapata-Salazar; Jorge Alejandro Ocampo-Garza; Jorge Ocampo-Candiani
Journal:  An Bras Dermatol       Date:  2022-09-24       Impact factor: 2.113

6.  Comparative Evaluation of Efficacy of Non-cultured Epidermal Cell Suspension and Epidermal Curettage in Stable Vitiligo.

Authors:  Shashank Tyagi; Suresh K Malhotra; Tejinder Kaur
Journal:  J Cutan Aesthet Surg       Date:  2021 Jan-Mar

Review 7.  It's Not All Sunshine: Non-sun-related Melanoma Risk-factors.

Authors:  Veronique Bataille
Journal:  Acta Derm Venereol       Date:  2020-06-03       Impact factor: 3.875

Review 8.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

Review 9.  Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo.

Authors:  Yinghan Wang; Shuli Li; Chunying Li
Journal:  Clin Rev Allergy Immunol       Date:  2021-07-20       Impact factor: 8.667

10.  An in-depth analysis reveals two new genetic variants on 22q11.2 associated with vitiligo in the Chinese Han population.

Authors:  Xianfa Tang; Hui Cheng; Lu Cheng; Bo Liang; Mengyun Chen; Xiaodong Zheng; Fengli Xiao
Journal:  Mol Biol Rep       Date:  2021-08-04       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.